Myocardial Iron metabolism in the regulation of cardiovascular diseases in rats

Cellular Physiology and Biochemistry

Volumn 25, Issue 6, 2010, Pages 587-594

  Zhao, Na ^a   Sun, Zhidan ^a   Egert, Ulrich ^a   Mao, Yuying ^a   Hang, Pengzhou ^a   Jiang, Xing ^a   Sun, Lihua ^a   Zhao, Jinlong ^a   Du, Zhimin ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Biopharmaceutical Key Laboratory of Heilongjiang Province   (China)

Author keywords

Diabetes; Divalent metal transporter 1; Iron; Metal transporter protein 1; Myocardial infraction; Transferrin receptor

Indexed keywords

CARRIER PROTEIN; FERRITIN; IRON; MALONALDEHYDE; METAL TRANSPORTER PROTEIN 1; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; CATION TRANSPORT PROTEIN; GLUCOSE BLOOD LEVEL; METAL TRANSPORTING PROTEIN 1; REACTIVE OXYGEN METABOLITE; SOLUTE CARRIER FAMILY 11- (PROTON-COUPLED DIVALENT METAL ION TRANSPORTERS), MEMBER 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DIABETES MELLITUS; DOWN REGULATION; FERRITIN BLOOD LEVEL; HEART INFARCTION; HEART MUSCLE ISCHEMIA; IRON BLOOD LEVEL; IRON METABOLISM; IRON OVERLOAD; LIPID DIET; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; STREPTOZOCIN DIABETES; ANIMAL; BLOOD; BODY WEIGHT; DIET RESTRICTION; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; HEART MUSCLE; METABOLISM; WISTAR RAT;

RATTUS;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CATION TRANSPORT PROTEINS; DIABETES MELLITUS; FASTING; FERRITINS; GENE EXPRESSION REGULATION; IRON; MALE; MALONDIALDEHYDE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RECEPTORS, TRANSFERRIN; SUPEROXIDE DISMUTASE;

EID: 77952980477     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000315077     Document Type: Article

References (31)

1. Ishizaka N, Saito K, Mitani H, Yamazaki I, Sata M, Usui S, Mori I, Ohno M, Nagai R: Iron overload augments angiotensin II-induced cardiac fibrosis and promotes neointima formation. Circulation 2002;106:1840-1846.
2. Sugishita K, Asakawa M, Usui S, Takahashi T: A case of iron overload cardiomyopathy. Int Heart J 2009;50:829-838.
3. Santos MM, de Sousa M, Rademakers LH, Clevers H, Marx JJ, Schilham MW: Iron overload and heart fibrosis in mice deficient for both p2-microglobulin and Rag1. Am J Pathol 2000;157:1883-1892.
4. Liu P, Olivieri N: Iron overload cardiomyopathies: new insights into an old disease. Cardiovasc Drugs Ther 1994;8:101-110.
5. Rajpathak SN, Crandall JP, Wylie-Rosett J, Kabat GC, Rohan TE, Hu FB: The role of iron in type 2 diabetes in humans. Biochim Biophys Acta 2009;1790:671-681.
6. Zheng Y, Li XK, Wang Y, Cai L: The role of zinc, copper and iron in the pathogenesis of diabetes and diabetic complications: therapeutic effects by chelators. Hemoglobin 2008;32:135-145.
7. Kazi TG, Afridi HI, Kazi N, Jamali MK, Arain MB, Sarfraz RA, Jalbani N, Ansari R, Shah AQ, Memon AU, Khandhro GA: Distribution of zinc, copper and iron in biological samples of Pakistani myocardial infarction (1st, 2nd and 3rd heart attack) patients and controls. Clin Chim Acta 2008;389:114-119.
8. Farhangkhoee H, Khan ZA, Mukherjee S, Cukiernik M, Barbin YP, Karmazyn M, Chakrabarti S: Heme oxygenase in diabetes-induced oxidative stress in the heart. J Mol Cell Cardiol 2003;35:1439-1448.
9. Turoczi T, Jun L, Cordis G, Morris JE, Maulik N, Stevens RG, Das DK: HFE mutation and dietary iron content interact to increase ischemia/reperfusion injury of the heart in mice. Circ Res 2003;92:1240-1246.
10. Wei W, Liu Q, Tan Y, Liu L, Li X, Cai L: Oxidative stress, diabetes, and diabetic complications. Hemoglobin 2009;33:370-377.
11. Burdo JR, Menzies SL, Simpson IA, Garrick LM, Garrick MD, Dolan KG, Haile DJ, Beard JL, Connor JR: Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J Neurosci Res 2001;66:1198-1207.
12. Ke Y, Chen YY, Chang YZ, Duan XL, Ho KP, Jiang DH, Wang K, Qian ZM: Post-transcriptional expression of DMT1 in the heart of rat. J Cell Physiol 2003;196:124-130.
13. Mims MP, Prchal JT: Divalent metal transporter 1. Hematology 2005;10:339-345.
14. Qian ZM, Tang PL: Mechanisms of iron uptake by mammalian cells. Biochim Biophys Acta 1995;1269:205-214.
15. Qian ZM, Wang Q: Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders. Brain Res Brain Res Rev 1998;27:257-267.
16. Zoller H, Koch RO, Theurl I, Obrist P, Pietrangelo A, Montosi G, Haile DJ, Vogel W, Weiss G: Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology 2001;120:1412-1419.
17. Veuthey T, D'Anna MC, Roque ME: Role of the kidney in iron homeostasis: renal expression of Prohepcidin, Ferroportin, and DMT1 in anemic mice. Am J Physiol Renal Physiol 2008;295:F1213-F1221.
18. 2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 2003;9:1187-1194.
19. Oudit GY, Trivieri MG, Khaper N, Liu PP, Backx PH: Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy. J Mol Med 2006;84:349-364.
20. Ai J, Yan X, Zhao L, Lu Y, Liang F, Cai B, Li G, Lu Y, Yang B: The protective effect of Daming capsule on heart function in streptozocin-induced diabetic rats with hyperlipidemia. Biol Pharm Bull 2009;32:1354-1358.
21. Yang B, Lin H, Xu C, Liu Y, Wang H, Han H, Wang Z: Choline produces cytoprotective effects against ischemic myocardial injuries: evidence for the role of cardiac M3 subtype muscarinic acetylcholine receptors. Cell Physiol Biochem 2005;16:163-174.
22. Rongzhu L, Suhua W, Guangwei X, Chunlan R, Fangan H, Junjie J, Aschner M: Zinc, copper, iron, and selenium levels in brain and liver of mice exposed to acrylonitrile. Biol Trace Elem Res 2009;130:39-47.
23. Han H, Wang H, Long H, Nattel S, Wang Z: Oxidative preconditioning and apoptosis in L-cells. Roles of protein kinase B and mitogen-activated protein kinases. J Biol Chem 2001;276:26357-26364.
24. Lu Y, Zhou J, Xu C, Lin H, Xiao J, Wang Z, Yang B: JAK/STAT and PI3K/AKT pathways form a mutual transactivation loop and afford resistance to oxidative stress-induced apoptosis in cardiomyocytes. Cell Physiol Biochem 2008;21:305-314.
25. Asghar O, Al-Sunni A, Khavandi K, Khavandi A, Withers S, Greenstein A, Heagerty AM, Malik RA: Diabetic cardiomyopathy. Clin Sci (Lond) 2009;116:741-760.
26. Smyth JW, Hong TT, Gao D, Vogan JM, Jensen BC, Fong TS, Simpson PC, Stainier D Y, Chi NC, Shaw RM: Limited forward trafficking of connexin 43 reduces cell-cell coupling in stressed human and mouse myocardium. J Clin Invest 2010;120:266-279.
27. Ward DT, Hamilton K, Burnand R, Smith CP, Tomlinson DR, Riccardi D: Altered expression of iron transport proteins in streptozotocin-induced diabetic rat kidney. Biochim Biophys Acta 2005;1740:79-84.
28. Voogd A, Sluiter W, van Eijk HG, Koster JF: Low molecular weight iron and the oxygen paradox in isolated rat hearts. J Clin Invest 1992;90:2050-2055
29. Shizukuda Y, Bolan CD, Tripodi DJ, Sachdev V, Nguyen TT, Botello G, Yau Y Y, Sidenko S, Inez E, Ali MI, Waclawiw MA, Leitman SF, Rosing DR: Does oxidative stress modulate left ventricular diastolic function in asymptomatic subjects with hereditary hemochromatosis? Echocardiography 2009;26:1153-1158.
30. Demant AW, Schmiedel A, Büttner R, Lewalter T, Reichel C: Heart failure and malignant ventricular tachyarrhythmias due to hereditary hemochromatosis with iron overload cardiomyopathy. Clin Res Cardiol 2007;96:900-903.
31. Tang WH, Wu S, Wong TM, Chung SK, Chung SS: Polyol pathway mediates iron-induced oxidative injury in ischemic-reperfused rat heart. Free Radic Biol Med 2008;45:602-610.